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ABSTRACT
Colorectal cancer is one of the most common cancers and is a leading cause of
death worldwide. It starts in the colon or the rectum, and they are often grouped
together because they have many features in common. It has been noticed that
colorectal cancer attacks young-onset patients who are less than 50 years of age in
increasing rates lately. Rapid developments in omics technologies have led them to be
highly regarded in the field of biomedical research for the early detection of cancer.
Omics data revealed how different molecules and clinical features work together in the
disease progression. However, Omics data sources are variants in nature and require
careful preprocessing to be integrated. A convolutional neural network is a class of
deep neural networks, commonly applied to analyze visual imagery. In this thesis,
we propose a model that converts one-dimensional vectors of omics into RGB images
to be integrated into the hidden layers of the convolutional neural network. The
prediction model will allow all different omics to contribute to the decision making
based on extracting the hidden interactions among these omics. These subsets of
interacted omics can serve as potential biomarkers for young-onset colorectal cancer.




﴾١٧٢﴿ تَعبُدونَ ُ يّاه ِإ ُكنتُم ِإن ِ ه َّ لِل وَاشكُروا رَزَقناكُم ما َطيِّباِت مِن كُلوا آمَنوا الَّذيَن هَا َأّيُ يا
O believers, eat what is good of the food We have given you, and be grateful to
God, if indeed you are obedient to Him. (172)
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God produced you from your mothers’ wombs knowing nothing, but gave you ears
and eyes and hearts so that you may be grateful. (78)
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The hot point in the medical research sector is cancer with a high economic and social
burden. Some remarkable achievements have been made; the precise mechanisms of
tumor initiation and growth, however, remain unclear. Cancer is a complex disease
of the entire body that includes many defects in the DNA, RNA, protein, metabolite
and medical imaging levels. Biological omics, including genomics, transcriptomics,
proteomics, metabolomics and radiomics, attempt to systematically explain carcino-
genesis at various biological levels, driving the shift of the paradigm of cancer research
from a single parameter model to a systemic multi-parameter model (M. Lu & Zhan,
2018). How we view the cancer genome has been reshaped by the incredible scien-
tific breakthroughs of the last decade; thus, our approach to the translation of this
information must also be.
Cancer genomics refers to the analysis of tumor genomes using different pro-
filing techniques, including (but not limited to) DNA methylation, copy number,
transcriptome and whole-genome sequencing, technologies that can be described as
omics collectively (Vucic et al., 2012). How we view the cancer genome has been
reshaped by the incredible scientific breakthroughs of the last decade; thus, our ap-
proach to the translation of this information must also be. For patients, each type of
omics data reflects a single view and it is difficult to use only a single omic to obtain
precise prediction. Many experiments have sequenced several forms of omics from
the same patient in order to obtain a holistic view of patients in genomics. Using
the Cancer Genome Atlas (TCGA), which offers more than ten thousand samples
of 33 cancer types, systematic studies have been carried out (Tomczak et al., 2015).
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The useful data makes an integrated analysis for systematic cancer prognosis analysis
based on multiple omics data (Chai et al., 2019). We consider the problem of classi-
fying cancer patients in this thesis; framed as a image-based supervised classification.
Our research aims to work on integrating images from multiomics data to classify
cancer patients.
We present a novel supervised model that consists of three convolutional neural
networks to handle multiple inputs (omics). The output of those three convolutional
neural networks will be discriminant features (from each input/omic) where they will
be flattened then fed into the last CNN to predict the young-onset colorectal cancer
patients.
In this chapter, we first discuss cancer and one of its types, colorectal cancer. We
then describe mutliomics, and their use in research, and biomarkers. In later sections
of this chapter, we will describe the problem at hand, followed by thesis objective &
organization.
1.1 Cancer
Cancer is a global epidemic. It is the first or second leading cause of death before
the age of 70 in ninety-one countries as of 2015, and is predicted to be the "leading
cause of death in the 21st century in all countries of the world" (Bray et al., 2018).
Over the past half century, epidemiology has not only helped researchers to ferret
out many of the non-inherited environmental causes of cancer, but also to estimate
how many annual cancer deaths can be attributed to each person. Although the
research can not be used to predict what will happen to any single individual, it
nevertheless offers widely useful data for people seeking to reduce their exposure to
known cancer-causing agents or carcinogens. It seems that cancer develops from the
effects of two distinct forms of carcinogens agents that damage genes involved in the
regulation of cell proliferation and migration are part of one of these groups. Cancer
occurs when a single cell, usually over several years, accumulates a number of these
mutations and eventually escapes from most proliferation restraints. The mutations
2
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cause additional alterations to be produced by the cell and its descendants and to
accumulate in increasingly large numbers, forming a tumor composed entirely of these
abnormal cells. Another group contains agents that do not damage genes, but instead
improve the growth of tumor cells or their precursors selectively. The biggest risk of
malignancies is that they can metastasize, causing some cells to spread and thereby
infect other areas of the body (Trichopoulos et al., 1996). Among the differences
between normal cells and cancerous cells in the human body are:
• Cancerous cells are basically many cells that continue to grow and divide.
• Cancerous cells differ from normal cells in size and shapes.
• Cancerous cells’ nuclei are larger and darker than normal cells’ nuclei.
• Cancerous cells have abnormal number of chromosomes that are arranged in a
disorganized fashion.
• Cancerous cells are shaped like a cluster of cells with no boundary.
1.1.1 Colorectal Cancer
Colorectal cancer (CRC) is one of the world’s most common cancers, with between
one and two million new cases diagnosed annually, making CRC the third most com-
mon cancer and the fourth most common cause of cancer-related death, trailing only
lung, liver and stomach cancers with 700,000 deaths each year. "By gender, CRC
is the second most common cancer in women (9.2%) and the third in men (10%)"
(Stewart & Wild, 2014). From 1990 to 2012, the incidence of CRC increased by over
200,000 new cases per year with 55% of them detected in western countries. But this
pattern is shifting due to some of those countries’ rapid growth over the past few years
(Brody, 2015). Figure 1 shows the four areas of a human colon (Ascending, Traverse,
Descending and Sigmoid) and the human rectum with a cross-sectional image of a
colon caner taken during colonoscopy.
3
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Figure 1: Human colon and rectum.
Colonoscopy is an exam used to diagnose changes or irregularities in the large intestine
(colon) and rectum, during which a long and flexible tube (colonoscope) is inserted
into the rectum. A small video camera at the tip of the tube helps the doctor to see the
inside of the entire colon. Polyps or other forms of irregular tissue may be removed (if
possible) during a colonoscopy via the lens. Also, during the same procedure, tissue
samples (biopsies) may be taken as well (?).
1.2 Multiomics
Multiomics is a modern approach during which the data sets of various omic groups
are combined. Genome, proteome, transcriptome, epigenome and microbiome are
the various omic strategies employed during multiomics. The addition of "omics" to
a molecular term implies a detailed evaluation of a group of molecules. The first
discipline of omics to emerge, genomics, concentrated on the study of whole genomes
as opposed to "genetics" that challenged human variants or single genes. A very
useful mechanism for mapping and analyzing particular genetic variants that lead to
both mendelian and complex diseases was provided by genomic studies. The omics
field was primarily driven by technological advances that made biological molecules
possible for cost-effective, high-throughput analysis (Hasin et al., 2017). The number
4
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of citations of articles containing the term "multiomics", found on Pubmed (a search
engine that accesses primarily MEDLINE (a bibliographic database of life sciences
and biomedical information) references and abstracts on life sciences and biomedical
topics), has gone up by almost 400% from 2010 until the year 2018.
Each type of omics data, on its own, usually provides a list of differences pertaining
to the disease. The data can be used as markers of the disease phase and to pro-
vide insight into which biological mechanisms or processes vary between the disease
and control groups. One major variance between the disease and control groups is
that cancer cells (in disease groups) are less specialized than normal cells (in control
groups). Meaning the latter mature with specific functions into very distinct cell
types, but cancer cells do not. This is one reason why cancer cells begin to divide
without stopping. Furthermore, cancer cells may ignore signals that typically tell cells
to stop dividing or to start a process known as programmed cell death, or apoptosis,
used by the body to get rid of unneeded cells.
Analysis of only one data form, however, is restricted to associations which often
represent reactive rather than causative processes. Integration of multiple forms of
omics data is also used to elucidate possible causative changes that contribute to
illness, or treatments’ objectives, which can then be evaluated in further molecular




A biomarker is defined as a measurable indicator of a biological process. There are
various types of cancer biomarkers. Some of which include:
• Prognostic biomarkers: those that predict the growth of cancer (Hahn &
MacLean, 1955).
• Diagnostic biomarkers: those that predict the existence of a disease or con-
dition of interest or a cancer subtype (Milioli et al., 2015).
• Predictive biomarkers: those that predict the chances of survival a patient
who is being treated with a specific drug (Dao et al., 2011).
• Progression biomarkers: those that predict whether the cancer is spreading
or not.
• Recurrence biomarkers: those that predict whether cancer will recur later
in a patient’s life (Umetani et al., 2006).
1.4 Problem Statement
Recent research has shown that CRC rates continue to increase in younger Canadians.
According to the government of Canada’s website, CRC is Canada’s second most
common cancer, with a man out of 14 and a woman out of 18 to be diagnosed
with it in their lifetimes. It has been estimated that 93% of CRCs occur in adults
who are 50 years or older. Multiomics data integration for Computer-aided diagnosis
(CAD) systems has been applied in cancer research. The main challenge faced by that
research is how to incorporate different resources of data, which may have different
characteristics, in one prediction model. The advances of deep neural networks helped
in integrating the multiomics data sets in different levels of the network layers. What
needs to be done is the extraction of the most discriminant features from each omic




In this thesis, we construct a multi-input classification system that can classify the
young-onset CRC patients from the older patients. The main objectives of this re-
search are:
• Building a CAD system to diagnose young-onset CRC patients with high perfor-
mance measurements for detecting them. This system can extract discriminant
features from each omic then integrate these features in the prediction system
using a dedicated convolutional neural network for each omic. The extracted
discriminant features will then get flattened, concatenated and fed to a merging
convolutional neural network for a collective prediction process.
• Finding a set of biomarkers for young-onset CRC patients. These biomarkers
can be clinical or genomic features.
1.6 Thesis Organization
The organization of the thesis is as follows. In Chapter 2, we present background in-
formation about the pillar concepts of our project. We also summarize the literature
review of some existing works in images classification using deep learning. In Chapter
3, we talk about the data used in this project and we describe our proposed method-
ology in detail. In Chapter 4, we provide the results we obtained from conducting
several experiments on the data sets that we collected from a publicly provided web
portal. We also present a comprehensive analysis and some insights of those acquired
results. In Chapter 5, we provide our conclusions from this project as well as discuss




This chapter discusses some background information about the main concepts that
are considered fundamental in our project. It also discusses previous work that was
done in regards to solving the problem stated in the previous chapter.
2.1 Artificial Intelligence
Artificial Intelligence (AI) refers to the intelligence shown by machines and that tries
to mimic human’s intelligence. Leading AI textbooks refer to AI as the study of
intelligent agents; agents refer to any system that perceives its environment and acts
in a way that maximizes how it successfully achieves its goals (Poole et al., 1998).
2.2 Machine Learning
Machine Learning (ML) is a branch of AI that aims to find patterns in vast quantities
of data. ML algorithms use statistics on data, which can include numbers, words,
pictures, clicks, etc. This data can be fed into an ML algorithm if it can be processed
digitally. These algorithms are categorized into three main areas which are supervised,
unsupervised, and semi-supervised ML algorithms. Supervised ML learning basically
happens when an ML algorithm tries to learn a function based on example input-
output pairs that maps an input to an output (Russell & Norvig, 2010). A function
is inferred, by the ML algorithm, that consists of a group of training examples from
the labeled training data (Mohri et al., 2012). In this type of learning, each example
8
2. LITERATURE REVIEW
is a pair made up of an input object (typically a vector) and a desired output value.
A supervised ML algorithms analyzes the training data then an inferred function is
generated, which can be used for mapping new examples. For unseen instances, an
optimal scenario would allow the algorithm to correctly determine the class labels.
This allows the learning algorithm to reasonably generalize from the training data to
unseen circumstances. After implementing an ML algorithm, it needs to be evalu-
ated for efficiency. There are many metrics for evaluating the performance of a ML
algorithm, some of these measurements are based on the confusion matrix. Figure
2 shows an illustration of a confusion matrix.
Figure 2: An illustration of a confusion matrix.
A confusion matrix, also know as an error matrix (Stehman, 1997), is a unique table
structure that allows for the visualization of a machine learn algorithm, usually a
supervised one, where the instances in a predicted class are expressed in each ma-
trix row and each column represents the instances present in an actual class (or vice
versa) (Powers, 2008). Some of the measurements used for evaluating ML algoritms’
9
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performances -that are based on the confusion matrix- include accuracy, sensitivity
(or recall), and specificity. Unsupervised machine learning is a type of machine learn-
ing that looks for previously undetected patterns in a data set that doesn’t have
preexisting labels and with a minimum of human supervision. This type of machine
learning, also known as self-organization, allows for modeling of probability densities
over inputs, in contrast to supervised learning that typically uses human-labeled data
(Hinton & Sejnowski, 1999). Principal component and cluster analysis are two of the
key methods used in unsupervised learning.
In unsupervised learning, cluster analysis is used to group or segment data sets
with common attributes to extrapolate algorithmic relationships. Principal compo-
nents are, basically, the directions of the data that explain a maximal amount of
variance, i.e., the lines that capture most information of the data. The correlation
between variance and data here is that the greater the variance held by a line, the
greater the variance of the data points along it, and the greater the variance along
a line, the greater the information it has. In cluster analysis, data that hasn’t been
labeled will be grouped, classified or categorized. Cluster analysis identifies common-
alities in the data and reacts based on the presence or absence of such commonalities
in each new piece of data. This approach helps detect anomalous data points that do
not fit into either group.
In semi-supervised learning approaches, during training, a small amount of labeled
data is combined with a large amount of unlabeled data. This type of ML falls between
unsupervised learning (with no labeled training data) and supervised learning (with
only labeled training data). When used in combination with a small amount of
labeled data, unlabeled data can yield significant changes in the learning accuracy.
The acquisition of labeled data for a learning problem often requires a skilled human
agent or a physical experiment. The cost associated with the labeling process may
become large. Also, acquiring fully labeled training sets is an infeasible process,
while acquiring unlabeled data is relatively inexpensive. So, in such situations, semi-
supervised learning can be of great practical value.
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Machine learning approaches were proposed to predict the outcomes of cancer.
Examples of such approaches inlcude the work of Hamzeh et al. (Hamzeh et al.,
2019) who proposed a supervised learning model to predict prostate cancer Gleason
score and the work of Abou Tabl et al. (Tabl et al., 2018) who proposed a semi-
supervised learning to predict the survivability of breast cancer treatments.
2.2.1 Feature Selection
Feature selection is a mechanism in ML in which a subset of relevant features are
selected to be used in constructing a model. Feature selection is used to simplify
models so that researchers and analysis can better understand them (James et al.,
2013). This process also shortens training time and reinforce generalization by re-
ducing overfitting. The core concept behind using feature selection is that the data
includes some features that are either redundant or irrelevant, and can thus be omit-
ted without much information loss (Spiliopoulou et al., 2015). Figure 3 shows an
overview of feature selection techniques.
Figure 3: Overview of feature selection techniques.
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2.2.2 Overfitting and Underfitting
Overfitting (in statistics) is the production of an analysis which corresponds too
closely or exactly to a particular set of data and may therefore fail to fit additional
data or predict future observations reliably. It refers to a model that models the
training data too well. This phenomenon arises when a model learns the detail and
noise of the training data so well that that it negatively impacts the performance of
the model on new data. This means that the noise or spontaneous variations in the
training data is picked up and learned as concepts by the model. The problem is that
these concepts do not extend to new data; thus, have a negative effect on the ability
of the model to generalize.
Underfitting refers to a model that can neither model the training data nor gener-
alize to new data. An underfit machine learning model is not a suitable model and
will be obvious as it will have poor performance on the training data. Underfitting
is often not discussed as it is easy to detect given a good performance metric. The
remedy is try alternate machine learning algorithms. Nevertheless, it does provide a
good contrast to the problem of overfitting.
2.2.3 Handling Class Imbalance
An imbalanced classification problem is an example of a classification problem where
the distribution of examples across the known classes is biased or skewed. The distri-
bution can vary from a slight bias to a severe imbalance where there is one example
in the minority class for hundreds, thousands, or millions of examples in the majority
class or classes. Imbalanced classifications pose a challenge for predictive modeling as
most of the machine learning algorithms used for classification were designed around
the assumption of an equal number of examples for each class. This results in models
with a poor predictive performance, specifically for the minority class. This is a prob-
lem because typically, the minority class is more important and therefore the problem
is more sensitive to classification errors for the minority class than the majority class.
12
2. LITERATURE REVIEW
To handle this problem, there are two main techniques:
• Upsampling the majority class using (for example) the SMOTE method.
SMOTE (Synthetic Minority Over-Sampling Technique) performs the basic task
of basic resampling (creating new data points for the minority class) not by
duplicating observations, but by creating new observations along the lines of a
randomly chosen point and its nearest neighbors.
• Downsampling the majority class, which can be achieved by omitting samples
from the majority class and assembling balanced bags of samples from both the
majority and minority classes then averaging the results. Example of this work
has been done by Elkarami (Elkarami et al., 2016).
2.3 Deep Learning
Deep Learning (DL) is a function of AI that mimics the functions of the human brain
in how it processes data and how it builds patterns to use them for the decision-making
process. DL is a subset of ML that has networks capable of unsupervised learning
from unstructured or unlabeled data. Also known as deep neural learning or deep
neural network. DL architectures such as deep neural networks, and Convolutional
Neural Networks (CNNs) have been applied to many fields such as bioinformatics,
drug design, medical image analysis and board game programs, where they have
achieved outcomes comparable to and in some cases exceeding the performance of
human experts (Krizhevsky et al., 2012).
13
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2.3.1 Artificial Neural Networks
Artificial Neural Networks (ANNs), mostly referred to as Neural Networks (NNs),
are computing systems that were loosely inspired by the animals brains’ neural net-
works (Chen et al., 2019). An ANN is based on a collection of connected nodes
called artificial neurons, which vaguely resemble a biological brain’s neurons. Each
connection between the nodes can transmit a signal to other neurons. An artificial
neuron receives a signal, processes it and then signal neurons connected to it. This
signal is a real number, and the output of each neuron is computed by a non-linear
function of the sum of its inputs. The connections between the neurons are called
edges. Neurons and edges typically have a weight that adjusts as learning proceeds.
The weight increases or decreases the strength of the signal at a connection. Neurons
can have a threshold such that a signal is sent only if that threshold is crossed by
the aggregate signal. Typically, neurons are aggregated into layers. Different layers
may perform different transformations on their inputs. Signals travel from the first
layer (the input layer), to the last layer (the output layer), possibly after traversing
the layers multiple times. Figure 4 shows an illustration of an ANN. Each circle in
the figure represents an artificial neuron and each arrow represents a connection from
the input of one artificial neuron to the output of another.
14
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Figure 4: A shallow ANN with one hidden layer.
2.3.2 Self-Organizing Maps
A Self-Organizing Map (SOM) is type of ANN that is trained (using unsupervised
learning) to generate a low-dimensional (typically two-dimensional), discretized rep-
resentation of the input space of the training samples called a map. SOMs differ from
other ANNs in that they apply competitive learning as opposed to error-correction
learning which means that only a single node is activated at each iteration in which
the features of an instance of the input vector are presented to the neural network. A
node is chosen according to the similarity, between the current input values and all
the nodes in the grid. The node with the smallest Euclidean difference between the
input vector and all nodes is chosen. By going through all the nodes present on the
grid, the entire grid will eventually match the complete input data set, with similar
nodes grouped together towards one area, and dissimilar ones separated.
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2.3.3 Convolutional Neural Networks
The use of Convolutional Neural Networks (CNNs) for image processing was pro-
posed in 1990 (Cun et al., 1990). The computing capacity revolution has promoted
the advancement of deep learning; deep learning with a CNN has shown outstanding
success in image classification in particular (Krizhevsky et al., 2012). A CNN is a
class of deep neural networks that is applied most often to analyze visual imagery
(Valueva et al., 2020). CNNs have applications in image and video recognition, im-
age classification, medical image analysis, natural language processing, and financial
time series. CNNs are regularized versions of multilayer perceptrons, which means
they are fully connected networks, i.e., each neuron in one layer is connected to all
neurons in the next layer. The fact that those networks are fully-connected makes
their data prone to be overfitted. Typical ways of regularization include adding some
form of magnitude measurement of weights to the loss function. CNNs regularize the
data by taking advantage of the hierarchical pattern in data and assembling more
complex patterns using smaller and simpler patterns. Therefore, on the scale of con-
nectedness and complexity, CNNs are on the lower extreme. CNNs vary from other
pattern recognition algorithms in that they combine feature selection with classifica-




Figure 5: A schematic diagram of a basic convolutional neural network (CNN)
architecture.
A CNN consists of an input and an output layer, as well as multiple hidden layers.
The hidden layers of a CNN typically consist of a series of convolutional layers that
convolve with a multiplication or other dot product. The activation function is usually
ReLU, and is subsequently followed by additional convolutions such as pooling layers,
fully connected layers and normalization layers, referred to as hidden layers because
their inputs and outputs are masked by the activation function and final convolution.
CNNs’ layers can be summarized as:
• Input Layer: the input layer in CNNs contain image data which are repre-
sented by a three dimensional matrix. These need to be reshaped into a single
column. For example, if we have an image of dimension 28 x 28 (which equals
784), we need to convert it into 784 x 1 before feeding into the input. If we
have m training examples, then input’s dimension will be 784 X m.
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• Convolution Layer: in this layer (sometimes called feature extractor layer)
features of the image get extracted. First, a part of image is connected to
this layer to perform convolution operation and to calculate the dot product
between receptive field (a local region of the image that has the same size as
that of the filter) and the filter. Result of the operation is a single integer of
the output volume. Then we slide the filter over the next receptive field of the
same input image by a Stride and repeat the same operation. We will repeat
the same process until we go through the whole image. The output will be the
input for the next layer. Convo layer also contains ReLU activation to make all
negative value to zero.
• Pooling Layer: this layer is used to reduce the spatial volume of input image
after convolution. It is used between two convolution layer. Max pooling is
used to reduce the spatial volume of input image.
• Fully connected layer: this layer involves weights, biases, and neurons. It
connects neurons in one layer to neurons in another layer.
• Softmax layer: this layer performs classification.
• Output layer: this layer contains the class label.
2.3.3.1 Activation Functions
In a neural network, inputs are fed into the neurons in the input layer. Each neuron
has a weight, and multiplying the input number with the weight gives the output
of the neuron, which is transferred to the next layer. The activation function is a
mathematical gate in between the input feeding the current neuron and its output
going to the next layer. The most common activation functions can be divided into
three groups: ridge functions, radial functions and fold functions.
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• Ridge activation functions: these functions are made up of univariate func-
tions acting on a linear combination of the input variables. Often used examples
of these activation functions include: Linear activation, ReLU activation, Heav-
iside activation, and Logistic activation.
• Radial activation functions: these functions are used in RBF networks,
which are ANNs with an output that linear combination of radial basis functions
of the inputs and neuron parameters. These activation functions can take many
forms, but they are usually found as one of the following functions: Gaussian,
Multiquadratics, Inverse multiquadratics and Polyharmonic splines.
• Folding activation functions: these functions are exhaustively used in the
pooling layers in CNNs and in output layers of multi-class classification net-
works. They perform aggregation over the inputs. In multiclass classification
the softmax activation is often used.
2.4 Summary of Previous Work
In this section, we summarize the papers that were studied for conducting this
project’s literature review.
• In the paper titled: iSOM-GSN: an integrative approach for transform-
ing multi-omic data into gene similarity networks via self-organizing
maps the authors introduced a systematic, generalized method, called iSOM-
GSN, used to transform multi-omic data with higher dimensions onto a two-
dimensional grid. They applied a CNN to predict disease states of various types
and based on the idea of Kohonens SOM, they generated a two-dimensional grid
for each sample for a given set of genes that represents a gene similarity net-
work. Their model produced nearly perfect classification accuracy and provided
an enhanced scheme for representation learning, visualization, dimensionality
reduction and interpretation of multi-omic data (Fatima & Rueda, 2020).
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• In the paper titled: Deep Learning Approach for Breast Cancer InClust
5 Prediction based on Multiomics Data Integration the authors pre-
sented a deep learning model based on multiomics data integration to predict
the five-year interval survival of breast cancer InClust 5. Their method was an
expansion of the iSOM-GSN model, where they created a feature map for each
omic data set instead of only one. The model incorporated the prediction of
the three CNNs using an integration layer. Their model was able to learn from
all the omic data sets and was able to classify one-dimensional sample vectors
using CNNs (Alkhateeb et al., 2020).
• In the paper titled: CancerSiamese: one-shot learning for primary and
metastatic tumor classification the authors proposed CancerSiamese,
which is a new one-shot learning model, to predict the cancer type of a query
primary or metastatic tumor sample. CancerSiamese received pairs of gene
expression profiles and learned a representation of similar or dissimilar cancer
types through two parallel CNNs joined by a similarity function. Their work
demonstrated, for the first time, the feasibility of applying one-shot learning for
expression-based cancer type prediction when gene expression data of cancer
types are limited (Mostav et al., 2020).
• In the paper titled: Representation of features as images with neighbor-
hood dependencies for compatibility with convolutional neural net-
works the authors presented a feature representation approach termed RE-
FINED (REpresentation of Features as Images with NEighborhood Depen-
dencies) to arrange high-dimensional vectors in a compact image form. They
generated a concise feature map in the form of a two-dimensional image. They
illustrated the superior predictive capabilities of REFINED in drug sensitivity
prediction scenarios (Bazgir et al., 2020).
• In the paper titled: DeepInsight: A methodology to transform a non-
image data to an image for convolution neural network architecture
the authors proposed DeepInsight which converts non-image samples into a
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well-organized image-form. DeepInsight enabled feature extraction through the
application of CNN for non-image samples to seize imperative information and
had shown promising results. To their knowledge, this was the first work to
apply CNN simultaneously on different kinds of non-image data sets (Sharma
et al., 2019).
• In the paper titled: A principled machine learning framework improves
accuracy of stage II colorectal cancer prognosis the authors addressed
the inherent limitations of current pathological reporting systems, which made
patient outcomes vary considerably within similarly staged patient cohorts,
through the use of machine learning. They introduced a data driven frame-
work which makes use of a large number of diverse types of features. Their
framework had an outstanding performance in predicting mortality in stage
II patients (AUROC=0:94), which exceeded that of current clinical guidelines
(AUROC=0:65), and their work was demonstrated on a cohort of 173 colorectal
cancer patients (Dimitriou et al., 2018).
• In the paper titled: Development and validation of a deep-learning algo-
rithm for the detection of polyps during colonoscopy the authors devel-
oped a DL algorithm using data from 1,290 patients, and validated it on newly
collected 27,113 colonoscopy images from 1,138 patients with at least one de-
tected polyp (per-image-sensitivity, 94.38%; per-image-specificity, 95.92%; area
under the receiver operating characteristic curve, 0.984), on a public database of
612 polyp-containing images (per-image-sensitivity, 88.24%), on 138 colonoscopy
videos with histologically confirmed polyps (per-image-sensitivity of 91.64%;
per-polyp-sensitivity, 100%), and on 54 unaltered full-range colonoscopy videos
without polyps (per-image-specificity, 95.40%) (Wang et al., 2018).
21
2. LITERATURE REVIEW
• In the paper titled: Early Colorectal Cancer Detected by Machine Learn-
ing Model Using Gender, Age, and Complete Blood Count Data the
authors wanted to validate an ML CRC detection model on a US community-
based insured adult population. Their model achieved 99% specificity and had
the highest accuracy in identifying right-sided CRCs (Hornbrook et al., 2017).
• In the paper titled: Deep learning based tissue analysis predicts out-
come in colorectal cancer the authors combined convolutional and recurrent
architectures to train a deep network to predict CRC outcome based on images
of tumour tissue samples. The novelty of their approach is that they directly
predicted patient outcome, without any intermediate tissue classification. Their
results suggested that state-of-the-art DL techniques can extract more prognos-
tic information from the tissue morphology of CRC than an experienced human
observer (Bychkov et al., 2018).
• In the paper titled: Colorectal Cancer Detection Based on Deep Learn-
ing the authors introduced a DL-based method in CRC detection and segmen-
tation from digitized H&E (hematoxylin and eosin) - stained histology slides.
They demonstrated that their NN approach produced a median accuracy of
99.9% for normal slides and 94.8% for cancer slides compared to pathologist-





In this chapter, we discuss our methodology and the data used in out project. We
tried different models to improve the performance measurements and to select the
best subset of features that present the problem. For each method, we tried to
optimize the performance by utilizing different parameter values. We also relied on
the literature to select the best practice at each step.
3.1 Data
The data set used in our project has been downloaded from the website cBioPrtal.
The source of the data is GDAC Firehose (with reference number 20160128) (cBio-
Portal for cancer genomics, n.d.). The data is made up of 3 omics, which are clini-
cal features, CNA (Copy Number Alteration) and gene expression, for each patient.
There are 162 patients, 81 of them are younger than 50 years of age, the rest are older
than 50. Figure 6 shows he block diagram of the proposed methodology.
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Figure 6: The block diagram of the proposed methodology.
3.2 Feature Selection
The first step in our project is utilizing a hybrid feature selection technique. In this
step we combine ranking and wrapping methods. More about this hybrid approach
in the following subsections.
3.2.1 Ranking
In this sub-step we rank the features that are correlated with the class using chi-
square to remove non-relevant features. The chi-square technique measures the de-
gree of independence of each feature in relation to the class. The following formula
explains how the measurement is done:
24
3. MATERIALS AND METHODOLOGY
χ2(Y,X) =
N × (AD − CB)
(A+ C)× (B +D)× (A+B)× (C +D)
(1)
Where A is the number of times feature X occurs and Y denotes the classes (less
than 50 or greater than 50). B is the number of times the feature X occurs without
class Y . C is the number of times class Y occurs without X. D is the number of
times neither X nor Y occurs. N is the total number of samples (In our project, the
total number of samples is 162).
The number of features in the omics gene expression and CNA is very high, which
will complicate the classification model and and which will lead to the problem of
Curse of Dimensionality, which means that the number of features is way larger
than the number of samples. The other reason (behind us performing ranking) is
that many features do not show the discriminant behavior required to identify the
classes of the CRC patients. To overcome those complications, we reduce the number
of features using chi-square.
3.2.2 Wrapping
On the resulting relevant features (that resulted from the ranking process), a wrap-
per method is utilized to extract a potential subset of features that can represent
the problem (that is the class). The wrapper method incorporates a random for-
est classifier with the Minimum Redundancy Maximum Relevance (mRMR)
technique.
The mRMR feature selection is performed at this stage to infer the interactions among
the features in each omic so that we are able to select the features with higher rel-
evance. mRMR also reduces the redundancy among the features by not considering
the correlated features. mRMR minimizes redundancy using the following formula:
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Where S is the set of features and I(i, j) is the mutual information between
features i and j. A high value of WI indicates that the feature is redundant.
The mRMR finds the relevant features by considering the class labels. It maximizes







where h is the class label.
Lastly, the algorithm maximizes the mutual information difference to select the fea-
tures using the following formula:
max(VI −WI) (4)
If the difference of mutual information has a high value, then it indicates that the
features can effectively separate our classes. We also use random forest with mRMR
feature selection that uses forward search to further reduce the number of selected
features. The following two tables show the results of performing our hybrid feature
selection process on the two omics: CNA and gene expression.
Note: We did not apply our hybrid feature selection approach on the clinical features
omic because this particular omic has few features.
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3.3 Creating Images Templates using SOM
We applied SOM on each omic data set to represent the data in a two-dimensional
space. We created a template image for the features in each of the three omics which
is then used to present the feature map (image) for each sample in that omic. We
obtained three omics templates, one for each of the used omic in this study. These
templates are depicted in Figures 9, 10 and 11.
Figure 7: Images template of the clinical features omic.
Figure 8: Images template of the CNA omic.
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Figure 9: Images template of the gene expression omic.
For the clinical features omic, eight features (genes) resulted in its image template.
They were (TUMOR57SUE, WESCORE, SEX, PATHM, PATHN, PATHT, PATH-
WAYS, WEIGHT). For the CNA omic, twelve features (genes) resulted in its im-
age template. They were (MR30E, SNORD45O, SNORD38B, SERBP1, TTLL10,
SLC35E2, AURKAIP1, MR1262, GNAT2, TINAGL1, UBR4, RNF186). For the gene
expression omic, fourteen features (genes) resulted in its image template. They were
(IQCG, POBEC3B, NUDT19, AOX2P, FAM153B, A4GNT, C10orf50, PLEKHG2,
KCNG4, UGT3A2, QRFPR, HBM, SSTR4, GUCY2E).
3.4 Omics’ Images Creation
Using the templates (which we mentioned in the previous section), SOM scans the
values of each feature. Then the values are converted into a color and the nodes in
each template are filled with that color. As an example for that, Figures 12, 13 and
14 show the resulting images for one of the young-onset CRC patients for the three
omics.
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Figure 10: Image of a patient sample clinical features omic.
Figure 11: Image of a patient sample CNA omic.
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Figure 12: Image of a patient sample gene expression omic.
For the clinical features omic, a patient’s sample’s features (genes) were assigned
purple, blue, orange, light brown and light green colors. For the CNA omic, a patient’s
sample’s features (genes) were assigned different shades of the colors purple and green.
For the gene expression omic, a patient’s sample’s features (genes) were assigned
different shades of the colors green, red and brown.
3.5 Designing a Multi-Input CNN
We have created a model that consists of three CNNs, each of those CNNs takes an
individual omic as an input then extracts the discriminant features from each omic.
These "extracted" features are then merged to be fed into the main CNN after
flattening these features. Figure 13 depicts the our model’s flow diagram.
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Figure 13: Design of multi-input CNNs.
For each omic we have a CNN that consists of:
• A convolutional layer that is called Convolution2D. This layer has 32 filters
and a kernel of size 3 X 3.
• An activation function called LeakyReLU, which is a leaky version of a Rec-
tified Linear Unit (ReLU), which allows a small gradient when the unit is not
active. This layer is the input layer that expects images.
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• A pooling layer called MaxPooling2D that takes the maximum and is config-
ured with a pool size of 2 X 2 (it halves the input in both spatial dimensions).
• A regularization layer (using dropout) called Dropout which is configured to
randomly exclude 25% of the neurons in the layer to reduce overfitting.
The output of the convolutional layers for the three inputs goes through a concate-
nation layer, and the result is converted from a two-dimensional matrix to a vector
by the flatten layer. This step allows standard fully connected layers to process the
output. Next we have a fully connected layer with 512 neurons, a Leaky rectifier
activation function followed by another Dropout layer configured to exclude 50% of
neurons, this integrated entire unit randomly processes the output from the flatten
layer. Finally, the output layer has neurons and a softmax activation function to
output probability-like predictions for each class.
For the optimization algorithm, we chose Adam (Adaptive Moment Estimation)
and for the loss function, we chose categorical_crossentropy. The optimization
algorithm minimizes the loss function. For the implementation, we used the default
setting of Google Colab. The structure of the model was built using Keras 2.3.1 on




In this chapter we present the results of our research in terms of determining set of
features (genes) that are associated with CRC as well as some performance measure-
ments for ML algorithms in general and how well our model performed in accordance
to those measurements.
4.1 9-Fold Cross Validation
Cross validation is any of many model validation techniques for estimating how the
results of a statistical analysis will generalize to an independent data set. It is mainly
used in settings where the model is predicting and the model’s creator wants to assess
how accurately that model can predict. In a prediction problem, a model is usually
given a data set of known data on which training is run called training data set, and
a data set of unknown data against which the model is tested called the testing data
set. The goal of cross-validation is to test the model’s ability to predict new data in
order to point out problems like overfitting or selection bias (Cawley & Talbot, 2010)
and to give an insight on how the model will generalize to an independent data set.
In k-fold cross-validation, the original sample is randomly partitioned into k equal
sized sub-samples. Of which, a single sub-sample is retained as the validation data
for testing the model, and the remaining sub-samples are used as training data. The
cross-validation process is then repeated k times, with each of the k sub-samples used




One advantage of k-fold cross validation is that all observations are used for both
training and validation, and each observation is used for validation exactly once. For
our model, We split the data set into nine equal sections with each section containing
sixteen samples. Then we perform a loop for nine times. Each time, we take one of the
sections for the testing, and the remaining are used for the training. Then, we return
the testing section and take the next section and use it for testing and the remaining
sections for training and so on. This technique maximizes the training phase to learn
from 88.88% of the samples each time, and, overall, tests all the samples. In other
words, 100% of the samples are tested.
Tables 1 and 2 show the results of performing our hybrid feature selection process on
the two omics: CNA and gene expression.
Table 1: Selected features from CNA omic.
Omic Selected Features Count
CNA
MR30E, SNORD45O, SNORD38B, SERBP1, TTLL10, SLC35E2,
AURKAIP1, MR1262, GNAT2, TINAGL1, UBR4, RNF186
12
Table 2: Selected features from gene expression omic.
Omic Selected Features Count
gene expression
IQCG, POBEC3B, NUDT19, AOX2P,
FAM153B, A4GNT, C10orf50, PLEKHG2, KCNG4,





To evaluate our model, we are using the following performance measurements:
• Sensitivity: (also called Recall) is a measure of the proportion of actual pos-
itive cases that got predicted correctly (also called true positive (TP) cases).
The existence of true positives implies that there will be another proportion of
actual positive cases, which would get predicted incorrectly as negative (also
described as false negative (FN) cases). This can also be represented in the
form of a false negative rate. The sum of sensitivity and false negative rate





• Specificity: is the proportion of actual negatives which were predicted cor-
rectly (also called true negative (TN) cases). The existence of true negatives
implies that there will be another proportion of actual negative cases, which
got predicted falsely as positive; thus, termed as false positives (FP) cases.
This proportion could also be called a false positive rate. The sum of specificity






• Precision: this measure is calculated as the number of TPs divided by the








• F-score: this measure is calculated from the precision and sensitivity of the
model. F-score is calculated using the following equation:
F − score = 2 · Precision · Sensitivity
Precision+ Sensitivity
(4)
• Accuracy: is the most intuitive performance measure and it is simply a ratio
of correctly predicted observation (TP & TN) to the total observations. A
high accuracy may suggest that our model is the among the best, but only when
we have symmetric data sets where values of false positive and false negatives
are almost same. Otherwise, we need to use other performance measurements




TP + FN + FP + TN
(5)
Next table is the confusion matrix that resulted from our experiments.
Table 3: Resulting confusion matrix.
.
True Positive True Negative
Predicted Positive 73 8
Predicted Negative 7 74
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• Sensitivity was calculated as 91.25%
• Specificity was calculated as 90.24%
• Precision was calculated as 90.12%
• F-score was calculated as 90.68%
• Accuracy was calculated as 90.74%
Comparing our model’s performance measures with another model that was built
for predicting the (FOLFOX) treatment response in metastatic or recurrent CRC
patients via machine learning algorithms (W. Lu et al., 2020), we establish that
our model achieved higher sensitivity and specificity that the latter. The treatment
response prediction model produced an average of 85% in the sensitivity measure and
an average of 64% in the specificity measure.
Resulting features from our hybrid feature selection approach on the two omics (CNA
and gene expression) were checked if they are associated with the CRC disease.
Tables 4 and 5 specify which of the resulting genes are associated with CRC and
which are not. Both tables indicate that five genes in the CNA omic and five genes
in the gene expression omic are associated with CRC.
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Table 5: Association of genes (resulting from hybrid feature selection on gene




















We used the literature to verify the associations between the findings (resulting genes)
and CRC. The verification of whether a gene is associated with CRC or not, was done
by finding a peer-reviewed paper that mentioned how a certain gene contributes in the
advancement of CRC, or if it (the specific gene) is found to be significantly expressed
in the CRC tissue. The expression of the gene can be in terms of gene expression,
DNA methylation or DNA gene copy. These verifications are summarized below:
• For the gene SLC35E2, it was found to be associated with lymphovascular
invasion in CRC. Also, DNA copy number was decreased for this gene in CRC
(Nakao et al., 2011).
• For the gene AURKAIP1, it was found to be negatively correlated to irinote-
can sensitivity for irinotecan sensitivity/resistance in CRC cell lines (X.-X. Li
et al., 2014).
• For the gene GNAT2, it was among a list of 524 genes for panel sequencing
found to be associated with CRC (Ge et al., 2019).
• For the gene UBR4, (Protein name: Retinoblastoma-associated factor 600),
it was found differentially-expressed in CRC metastatic cells (Luque-Garcia et
al., 2010).
• For the gene RNF186, it was found that the expression of RNF186 was
decreased in CRC tissues compared to corresponding normal tissues. It was
also demonstrated that upregulation of RNF186 suppressed CRC cell growth
and migration in vitro and in vivo (Ji et al., 2020).
• For the gene FAM153B, it was among a list of 524 genes for panel sequencing
found to be associated with CRC (Ge et al., 2019).
• For the gene PLEKHG2, it was found to be a part of a lncRNA-miRNA-
mRNA ceRNA network and ceRNAs suggest the transformation from IBD to
CRC. Also it was found to be responsible of positive regulation of the apoptotic
process(Sun et al., 2019).
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• For the gene UGT3A2, it was among a list of 524 genes for panel sequencing
found to be associated with CRC (Ge et al., 2019).
• For the gene QRFPR, it was among a list of 524 genes for panel sequencing
found to be associated with CRC (Ge et al., 2019).
• For the gene SSTR4, the hypermethylation of this gene is frequently observed
in CRC (J. Li et al., 2017).
We analyzed the protein expression of some of the the resulting genes. Chen-Chu
et al. (Chu et al., 2018) reported that gene SLC35E2 was among another 27 genes
that were found to be differentially expressed in CRC. Using GO and KEGG pathway
analyses, the researchers performed a comprehensive analysis to discover the biologi-
cal functions of differentially expressed circular RNAs. They found that SLC35A2
created 9 protein interactions with the rest of the 27 reported genes. For the gene
AURKAIP1 (AUrora Kinase A-Interacting Protein), it was found among other mi-
tochondrial ribosomal proteins that perform synthesis in many human diseases (in-
cluding CRC) (Gopal & Rajkumar, 2016). The gene PLEKHG2 was found among
other Rho family guanine nucleotide exchange factors (RhoGEFs) genes and those
are found to be over-expressed and responsible for the the protein synthesis in the
CRC tissue in comparison to adjacent normal tissues. This set of genes facilitates the
progression of CRC (Lee, 2016). The SSTR4 protein expression has an association
with the clinico-pathological factors, cell proliferation, Bcl-2 and p53 expression in
CRC cells (Qiu et al., 2006).
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Conclusion and Future Work
In this chapter we present what we concluded from this project and suggest directions
for future work.
5.1 Conclusion
Our supervised learning model was able to consider all omics with no bias or directive
from a specific omic. We were able to achive this thesis’s objective of taking data from
a publicly available web portal, pre-process that data, create SOM features images
which were fed into individual CNNs and then we were able to (eventually) classify
the cancer data sets into specific labels (classes). The main advantages that we were
able to achieve in this project are handling multiple input data sets and the ability to
select discriminant features that best represent the data set. We examined scientific
papers about how those discriminant features (genes) participate in the biological
process of advancing or suppressing cancer.
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5.2 Future Work
This work can be further extended by:
• Verifying the findings of the gene expression and CNA omics using wet lab
experiments (Tabl et al., 2018) and pathway analysis. Pathway analysis can
be done from the literature and using KEGG database (Ogata et al., 1998).
KEGG database "is a collection of manually drawn pathway maps represent-
ing our knowledge of the molecular interaction, reaction and relation networks
for metabolism, genetic information processing, cellular processes, organismal
systems, human diseases and drug development" (KEGG PATHWAY Database,
n.d.).
• Trying a different dimensionality reduction technique for mapping, other than
SOM, like Principal Component Analysis (PCA), Fisher Linear Discriminant
or Multiple Discriminant Analysis (MDA).
• Applying the proposed methodology on multi-input data sets (more than three)
to verify the prediction strength of the model. Then, comparing the results with
state-of-the-art methods for multi-input data sets.
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